SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 34 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 659,252 | $12,974,000 | 12.51% |
| RA Capital Management | 4,681,858 | $92,139,000 | 2.79% |
| Cormorant Asset Management, LP | 858,382 | $16,893,000 | 0.67% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $37,115,000 | 0.55% |
| Eventide Asset Management | 425,000 | $8,364,000 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 693,625 | $13,651,000 | 0.03% |
| Zimmer Partners, LP | 100,000 | $1,968,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,341,211 | $45,657,000 | 0.01% |
| Citadel Advisors | 1,017,482 | $20,024,000 | 0.01% |
| CREDIT SUISSE AG/ | 53,970 | $1,062,000 | 0.00% |